Human medicinehttps://www.ema.europa.eu/en/homepageHuman medicineen-gbCopyright: (C) European Medicines AgencySun, 02 Jun 2024 09:41:24 +0200Tue, 30 Apr 2024 12:47:00 +0200Human medicines European public assessment report (EPAR): Bydureon, exenatide, Date of authorisation: 17/06/2011, Revision: 26, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/bydureonHuman medicines European public assessment report (EPAR): Bydureon, exenatide, Date of authorisation: 17/06/2011, Revision: 26, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/bydureonTue, 30 Apr 2024 12:47:00 +0200Human medicineBydureon : EPAR - All Authorised presentationshttps://www.ema.europa.eu/system/files/documents/all-authorised-presentations/h-2020-aa_en.pdfBydureon : EPAR - All Authorised presentationshttps://www.ema.europa.eu/system/files/documents/all-authorised-presentations/h-2020-aa_en.pdfTue, 20 Aug 2019 02:00:00 +0200Human medicine